1. A, Effect of folate-FITC (500 nmol/kg, 5 days/week) and/or sunitinib (20 mg/kg daily) therapy on the growth of M109 tumors in Balb/c mice.
A, Effect of folate-FITC (500 nmol/kg, 5 days/week) and/or sunitinib (20 mg/kg daily) therapy on the growth of M109 tumors in Balb/c mice. B, Average weights of excised tumors from M109 tumor-bearing Balb/c mice dosed with the indicated therapies. Data are mean ± SEM (n = 5–7). Means that do not share a letter are significantly different, P < 0.05.
N. Achini Bandara et al. Mol Cancer Ther 2017;16:
©2017 by American Association for Cancer Research